Last updated: Nov 20, 2026, 12:00 AM

Grace Therapeutics, Inc. Exchange (NASDAQ, USD)

GRCE

1.73
+0.01 (+0.58%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-42.33%
3 year return (CAGR)
-6.99%
5 year return (CAGR)
-29.62%
10 year return (CAGR)
-30.08%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
36.39M
Price/Sales
-
Ent value
24.50M
Price/Book
0.75
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-43.17%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open1.73
Daily high1.76
Daily low1.70
Daily Volume28K
All-time high1953.60
1y analyst estimate5.97
Beta0.41
EPS (TTM)-1.24
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Grace Therapeutics, Inc.'s growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
GRCES&P500
Current price drop from All-time high-99.91%-6.28%
Highest price drop-99.91%-56.47%
Date of highest drop17 Nov 20269 Mar 2009
Avg drop from high-86.03%-10.64%
Avg time to new high50 days12 days
Max time to new high3344 days1805 days